REVEALED: How to Potentially Make Up to Tens of Thousands of Rupees Within a Few Hours...
Here is the latest financial fact sheet of Dishman Pharma. For more details, see the Dishman Pharma quarterly results and Dishman Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | 2.9 |
No. of shares | m | 161.39 |
% ch week | % | 3.5 |
% ch 1-mth | % | -2.4 |
% ch 12-mth | % | 96.4 |
52 week H/L | Rs | 346.3/127.6 |
No. of Mths Year Ending |
12 Mar-12* |
12 Mar-13* |
12 Mar-14* |
12 Mar-15* |
12 Mar-16* |
5-Yr Chart Click to enlarge
|
---|
DISHMAN PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 107 | 122 | 107 | 183 | 374 | |
Low | Rs | 35 | 42 | 39 | 83 | 129 | |
Sales per share (Unadj.) | Rs | 139.3 | 157.7 | 171.7 | 196.9 | 197.8 | |
Earnings per share (Unadj.) | Rs | 7.0 | 12.4 | 13.5 | 14.8 | 21.2 | |
Diluted earnings per share | Rs | 3.5 | 6.2 | 6.8 | 7.4 | 10.6 | |
Cash flow per share (Unadj.) | Rs | 16.5 | 22.8 | 27.0 | 33.5 | 34.7 | |
Dividends per share (Unadj.) | Rs | 1.20 | 1.20 | 1.20 | 2.00 | 2.00 | |
Adj. dividends per share | Rs | 0.60 | 0.60 | 0.60 | 1.00 | 1.00 | |
Dividend yield (eoy) | % | 1.7 | 1.5 | 1.6 | 1.5 | 0.8 | |
Book value per share (Unadj.) | Rs | 115.3 | 128.2 | 146.4 | 153.4 | 179.9 | |
Adj. book value per share | Rs | 57.7 | 64.1 | 73.2 | 76.7 | 89.9 | |
Shares outstanding (eoy) | m | 80.69 | 80.69 | 80.69 | 80.69 | 80.69 | |
Bonus/Rights/Conversions | - | - | - | - | - | ||
Price / Sales ratio | x | 0.5 | 0.5 | 0.4 | 0.7 | 1.3 | |
Avg P/E ratio | x | 10.1 | 6.6 | 5.4 | 8.9 | 11.9 | |
P/CF ratio (eoy) | x | 4.3 | 3.6 | 2.7 | 4.0 | 7.2 | |
Price / Book Value ratio | x | 0.6 | 0.6 | 0.5 | 0.9 | 1.4 | |
Dividend payout | % | 17.1 | 9.7 | 8.9 | 13.5 | 9.4 | |
Avg Mkt Cap | Rs m | 5,729 | 6,617 | 5,902 | 10,691 | 20,306 | |
No. of employees | `000 | 1.0 | 1.1 | 0.9 | 0.9 | 0.8 | |
Total wages/salary | Rs m | 2,941 | 3,509 | 4,123 | 4,232 | 5,355 | |
Avg. sales/employee | Rs Th | 11,541.3 | 12,059.0 | 14,848.0 | 18,430.9 | 19,252.7 | |
Avg. wages/employee | Rs Th | 3,019.6 | 3,326.2 | 4,419.4 | 4,909.6 | 6,459.5 | |
Avg. net profit/employee | Rs Th | 582.8 | 950.6 | 1,171.2 | 1,389.9 | 2,064.1 |
DISHMAN PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 11,241 | 12,722 | 13,853 | 15,887 | 15,961 | |
Other income | Rs m | 129 | 178 | 249 | 869 | 265 | |
Total revenues | Rs m | 11,370 | 12,900 | 14,102 | 16,757 | 16,226 | |
Gross profit | Rs m | 2,245 | 2,901 | 3,321 | 3,128 | 4,103 | |
Depreciation | Rs m | 765 | 838 | 1,086 | 1,507 | 1,091 | |
Interest | Rs m | 729 | 788 | 921 | 897 | 944 | |
Profit before tax | Rs m | 879 | 1,453 | 1,564 | 1,593 | 2,334 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 1 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 312 | 450 | 471 | 394 | 624 | |
Profit after tax | Rs m | 568 | 1,003 | 1,093 | 1,198 | 1,711 | |
Gross profit margin | % | 20.0 | 22.8 | 24.0 | 19.7 | 25.7 | |
Effective tax rate | % | 35.4 | 31.0 | 30.1 | 24.8 | 26.7 | |
Net profit margin | % | 5.0 | 7.9 | 7.9 | 7.5 | 10.7 |
DISHMAN PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 6,239 | 6,733 | 8,245 | 10,135 | 11,018 | |
Current liabilities | Rs m | 6,547 | 7,127 | 9,028 | 11,048 | 9,517 | |
Net working cap to sales | % | -2.7 | -3.1 | -5.7 | -5.7 | 9.4 | |
Current ratio | x | 1.0 | 0.9 | 0.9 | 0.9 | 1.2 | |
Inventory Days | Days | 87 | 97 | 112 | 103 | 110 | |
Debtors Days | Days | 61 | 21 | 38 | 50 | 35 | |
Net fixed assets | Rs m | 14,391 | 14,579 | 15,717 | 15,827 | 16,304 | |
Share capital | Rs m | 161 | 161 | 161 | 161 | 161 | |
"Free" reserves | Rs m | 8,225 | 9,051 | 10,031 | 11,167 | 12,907 | |
Net worth | Rs m | 9,307 | 10,345 | 11,813 | 12,378 | 14,516 | |
Long term debt | Rs m | 5,121 | 4,336 | 4,121 | 3,302 | 4,189 | |
Total assets | Rs m | 22,490 | 22,911 | 26,277 | 28,089 | 29,805 | |
Interest coverage | x | 2.2 | 2.8 | 2.7 | 2.8 | 3.5 | |
Debt to equity ratio | x | 0.6 | 0.4 | 0.3 | 0.3 | 0.3 | |
Sales to assets ratio | x | 0.5 | 0.6 | 0.5 | 0.6 | 0.5 | |
Return on assets | % | 5.8 | 7.8 | 7.7 | 7.5 | 8.9 | |
Return on equity | % | 6.1 | 9.7 | 9.3 | 9.7 | 11.8 | |
Return on capital | % | 11.1 | 15.3 | 15.6 | 15.9 | 17.5 | |
Exports to sales | % | 30.3 | 28.3 | 27.8 | 22.6 | 24.8 | |
Imports to sales | % | 7.2 | 4.7 | 6.3 | 5.6 | 3.7 | |
Exports (fob) | Rs m | 3,404 | 3,595 | 3,855 | 3,598 | 3,956 | |
Imports (cif) | Rs m | 806 | 599 | 869 | 891 | 596 | |
Fx inflow | Rs m | 3,974 | 4,210 | 3,966 | 4,576 | 4,952 | |
Fx outflow | Rs m | 905 | 695 | 954 | 974 | 697 | |
Net fx | Rs m | 3,069 | 3,515 | 3,011 | 3,601 | 4,255 |
DISHMAN PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,536 | 1,651 | 3,445 | 2,937 | 2,786 | |
From Investments | Rs m | -1,040 | -1,173 | -2,568 | -1,581 | -1,529 | |
From Financial Activity | Rs m | -680 | -502 | -741 | -1,420 | -941 | |
Net Cashflow | Rs m | -185 | -23 | 136 | -64 | 316 |
Share Holding
|
Company Information
|
CHM: Janmejay R. Vyas (MD) | COMP SEC: Tushar D. Shah | YEAR OF INC: 1983 | BSE CODE: 532526 | FV (Rs): 2 | DIV YIELD (%): 0.3 |
More Pharmaceuticals Company Fact Sheets: ALKEM LABORATORIES AJANTA PHARMA STRIDES PHARMA SCIENCE CIPLA WYETH
Compare DISHMAN PHARMA With: ALKEM LABORATORIES AJANTA PHARMA STRIDES PHARMA SCIENCE CIPLA WYETH
Compare DISHMAN PHARMA With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 385 points, down 0.8% at 51,059 levels.
Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.
An Indian company founded three decades ago in a garage caught my attention...
More